AG Health announced their official sponsorship of the National Women’s Hockey League (NWHL)
DORAL, Fla. — AG Health, a Florida-based innovator and pioneer of Endocannabinoid Nutrition (ECN), announced their official sponsorship of the National Women’s Hockey League (NWHL).
The recent deal makes the NWHL the first National Professional Sports League to accept a sponsorship by a company in the hemp industry. AG Health developed their VEDA division to address the deficiency in Endocannabinoid Nutrition (ECN) that affects the health and well-being of individuals all over the world.
The sponsorship includes two key points among others: VEDA is the presenting sponsor of the historic Champions Cup game on Saturday in Princeton, where the NWHL champion Metropolitan Riveters will play SDHL champion Lulea Hockey in the first-ever event of its kind. In addition, VEDA will be the title sponsor of the VEDA/NWHL Player of the Week Award during the 2018-19 season.
“This is a huge step for Endocannabinoid Nutrition and its place in the world of sports,” said Robert Chavez, CEO of AG Health.
As The Leaders in Endocannabinoid Nutrition, VEDA takes a strong stand on research and education.
“We are excited to engage in the communities that have welcomed the NWHL and look forward to empowering female athletes and promoting women’s hockey. We are humbled to be a part in the present and future of this historic period of The NWHL,” says Marvin Degon IV, former professional hockey player and Director of Athletics at AG Health.
Degon is scheduled to visit each of the five NWHL teams to educate players and staff on the benefits of proper Endocannabinoid Nutrition in the world of sports.
“We are excited for VEDA’s involvement in the NWHL,” said Dani Rylan, commissioner of the league for the NWHL. “Their support of our first-ever Champions Cup and sponsorship of the player of the week award is greatly appreciated, and we look forward to working with their team.”
VEDA products are formulated to provide the highest bioavailability, the most effective delivery systems and to ensure customer accessibility and affordability. Driven by our principles in healthcare, nutrition and wellness, VEDA products were developed to positively and significantly impact global population health. At AG Health, we believe that everyone should have access to quality ECN products to enhance their health and well-being.
VEDA provides a variety of ECN products including; tincture, spray and vape. The VEDA Sports line is set to launch Fall 2018 with, VEDA Pet, and VEDA Hospitality to follow.
VEDA ECN is a division of Avant-Garde Holdings Americas, Inc., dba AG Health, a research and development company of bio-pharmaceutical products, big data analytics, health information and disease management, drug formulations and commerce solutions for the U.S. cannabis and hemp industry.
For more information on AG Health, visit the company’s website athttp://www.aghealth.net